A clotting time test starts with venous blood drawn into a tube containing anticoagulant; the sample is centrifuged to obtain plasma. In the lab, specific reagents are added—thromboplastin for PT (extrinsic pathway) or activator plus calcium for aPTT (intrinsic pathway)—and a timer records seconds until clot formation. Results help assess bleeding risk and guide anticoagulant therapy.

I’m not sure which test “BTCT” refers to. Could you confirm the full test name or the condition it screens for, and your country or city? Costs vary widely by test type and location — from low-cost public clinic rates to higher private-lab prices. With the exact test and location I can give a reliable cost range based on reputable health guidance.

A clotting test checks how quickly blood clots to assess bleeding or thrombotic risk. It’s used before surgery, to diagnose bleeding disorders (e.g., hemophilia, von Willebrand disease), detect liver disease or vitamin K deficiency, evaluate unexplained bruising or clotting, and to monitor anticoagulant therapy (warfarin/heparin). Results guide treatment decisions and help detect conditions like disseminated intravascular coagulation.

A common clotting time test is the prothrombin time (PT), which assesses the extrinsic and common coagulation pathways. The activated partial thromboplastin time (aPTT) evaluates the intrinsic and common pathways. For people on warfarin, PT is reported as the international normalized ratio (INR) to standardize results. These tests diagnose bleeding disorders and monitor anticoagulant therapy.

Fasting is generally not required for clotting tests such as PT/INR, aPTT, D‑dimer, or fibrinogen. If your clinician orders other tests that do require fasting (for example, lipids or glucose), follow those instructions. Always tell the healthcare team about anticoagulant medications, supplements (like vitamin K), or recent procedures, and follow any specific preparation directions they provide.

Several disorders alter clotting time: inherited bleeding disorders (hemophilia A/B, von Willebrand disease), platelet disorders or thrombocytopenia, liver disease (reduced clotting factor synthesis), vitamin K deficiency, disseminated intravascular coagulation (DIC), sepsis, and hematologic malignancies such as leukemia. Evaluation with tests (PT, aPTT, platelet count) helps diagnose the specific cause and guide treatment.